Search Results - "Keiichi Fujiwara"
-
1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
Published in The New England journal of medicine (19-12-2019)“…When used as maintenance therapy, the PARP inhibitor olaparib provided a significant progression-free survival benefit in women with ovarian cancer who had a…”
Get full text
Journal Article -
2
Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy
Published in Cancer (15-12-2019)“…According to the statement from the 5th Ovarian Cancer Consensus Conference in 2015, the primary systemic chemotherapy for advanced ovarian cancer is a…”
Get full text
Journal Article -
3
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
Published in The New England journal of medicine (14-11-2019)“…An NCI-sponsored, randomized clinical trial tested whether patients with relapsed ovarian cancer might benefit from surgical debulking of tumors followed by…”
Get full text
Journal Article -
4
Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma
Published in Nature communications (31-10-2019)“…Carcinosarcoma (CS) of the uterus or ovary is a rare, aggressive and biphasic neoplasm composed of carcinoma and sarcoma elements. Previous genomic studies…”
Get full text
Journal Article -
5
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
Published in Journal of clinical oncology (01-06-2019)“…To evaluate the impact of two different intraperitoneal (IP) chemotherapy regimens on progression-free survival (PFS) among women with newly diagnosed advanced…”
Get full text
Journal Article -
6
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
Published in The lancet oncology (01-06-2017)“…Summary Background Platinum-based chemotherapy doublets are a standard of care for women with ovarian cancer recurring 6 months after completion of initial…”
Get full text
Journal Article -
7
Adipose tissue area is a predictive biomarker for the efficacy of pegylated liposomal doxorubicin in platinum‐refractory/resistant ovarian cancer
Published in Cancer medicine (Malden, MA) (01-07-2023)“…Background Pegylated liposomal doxorubicin (PLD), an anthracycline agent, is widely used as a treatment option for platinum‐refractory/resistant epithelial…”
Get full text
Journal Article -
8
Upper Lobe-predominant Autoimmune Pulmonary Alveolar Proteinosis
Published in Internal Medicine (15-05-2023)Get full text
Journal Article -
9
Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry
Published in Japanese journal of clinical oncology (22-10-2020)“…The Cancer-VTE Registry evaluates the occurrence and management of venous thromboembolism in Japanese participants with major solid tumors. Using Registry…”
Get full text
Journal Article -
10
The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer
Published in Japanese journal of clinical oncology (01-08-2019)“…Immune checkpoint inhibitors (ICIs) have demonstrated long survival for the treatment of advanced non-small cell lung cancer (NSCLC). However, the effect and…”
Get full text
Journal Article -
11
SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study
Published in International journal of gynecological cancer (01-05-2019)“…Radical hysterectomy and complete pelvic lymphadenectomies are the most commonly performed procedures for women with early-stage cervical cancer. Sentinel…”
Get more information
Journal Article -
12
Incorporation of pazopanib in maintenance therapy of ovarian cancer
Published in Journal of clinical oncology (20-10-2014)“…Pazopanib is an oral, multikinase inhibitor of vascular endothelial growth factor receptor (VEGFR) -1/-2/-3, platelet-derived growth factor receptor (PDGFR)…”
Get full text
Journal Article -
13
Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis
Published in Journal of gastroenterology (01-12-2008)“…Background The diagnosis of acute-onset autoimmune hepatitis (AIH) has been difficult because patients do not always show clinicopathological features typical…”
Get full text
Journal Article -
14
High recovery rate of consciousness by high‐volume filtrate hemodiafiltration for fulminant hepatitis
Published in Hepatology research (01-02-2019)“…Aim An artificial liver support (ALS) system sustaining patients with acute liver failure (ALF) in good condition until recovery of the native liver or…”
Get full text
Journal Article -
15
Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression
Published in International journal of cancer (15-04-2016)“…Folate receptor alpha (FRA) is a GPI‐anchored glycoprotein and encoded by the FOLR1 gene. High expression of FRA is observed in specific malignant tumors of…”
Get full text
Journal Article -
16
Clinicopathological features of severe and fulminant forms of autoimmune hepatitis
Published in Journal of gastroenterology (01-03-2011)“…Background and aims Diagnosis of the acute presentation of autoimmune hepatitis (AIH) is difficult because patients do not always show typical…”
Get full text
Journal Article -
17
Pembrolizumab-induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in Non-small Cell Lung Cancer
Published in Internal Medicine (01-03-2019)“…We herein report a 78-year old man with squamous cell carcinoma of the lungs treated with pembrolizumab. At 10 days after the administration of pembrolizumab,…”
Get full text
Journal Article -
18
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826
Published in Cancer science (01-11-2022)“…Pembrolizumab plus chemotherapy with or without bevacizumab demonstrated prolonged progression‐free survival (PFS) and overall survival (OS) versus…”
Get full text
Journal Article -
19
Infectious complications and timing for liver transplantation in autoimmune acute liver failure in Japan: a subanalysis based on nationwide surveys between 2010 and 2015
Published in Journal of gastroenterology (01-09-2020)“…Background The prognosis of autoimmune acute liver failure (ALF) without liver transplantation (LT) is poor worldwide. We subanalyzed infectious complications…”
Get full text
Journal Article -
20
Successful Treatment with Benralizumab for Allergic Bronchopulmonary Aspergillosis That Developed after Disastrous Heavy Rainfall in Western Japan
Published in Internal Medicine (01-05-2021)“…We herein report a 56-year-old woman who developed allergic bronchopulmonary aspergillosis (ABPA) possibly due to fungal exposure after disastrous heavy…”
Get full text
Journal Article